News Articles for "Non-hodgkin Lymphoma"
Seattle Genetics Inc. plans to proceed with a late-stage study of a possible additional use for its lymphatic cancer treatment Adcetris after releasing res...read more
Blood cancer patients are being encouraged to bring along a family member to participate in a world-first study hoping to uncover the causes of follicular ...read more
A panel that advises the European Union's chief medical agency is recommending a new approval for the cancer drug Revlimid, the drug's maker, Celgene Corp...read more
WA study of thalidomide as cancer drug
Scientists at the University of Western Australia have received funding to carry out research on the potential of the infamous morning sickness drug thalid...read more